摘要
2023年,中国生物医药行业进入自主创新引领的关键转变时期。2024年,生物医药产业将持续优化行业生态,平衡各方需求,注重差异化发展。上海市药物研发协同创新中心通过多轮头脑风暴圆桌会议,对我国生物医药行业进行了2024年度展望,提出生物医药行业需要提振信心,在困难中抓住机遇,追求高质量平衡发展。
In 2023,China's biopharmaceutical industry has undergone a significant transformation driven by independent innovation.In 2024,the biopharmaceutical industry will continue to optimize the industry ecosystem,harmonize diverse needs,and focus on differentiated development.Through multiple rounds of brainstorming roundtables,Shanghai Center for Innovation Drug Discovery and Development(SCIDDD)made the 2024 annual outlook on China's biopharmaceutical industry,proposing that the biopharmaceutical industry needs to boost confidence,seize opportunities amid difficulties,and pursue high-quality and balanced development.
作者
戈乾玮
孔令辉
邵黎明
GE Qianwei;KONG Linghui;SHAO Liming(School of Pharmacy,Fudan University,Shanghai 201203,China;Shanghai Center for Innovation Drug Discovery and Development,Shanghai 201203,China)
出处
《药学进展》
CAS
2024年第3期237-240,I0003,I0004,共6页
Progress in Pharmaceutical Sciences
关键词
医药行业
高质量平衡发展
创新药
pharmaceutical industry
high-quality and balanced development
innovative drug
